No. of patients (incidence rate/100 person-years) |
Hazard ratio (95% CI) | P value | |||
---|---|---|---|---|---|
Apixaban (n=13,604) |
Warfarin (n=12,918) |
||||
Stroke/SE | 147 (1.51) | 218 (2.09) |
|
0.82 (0.66–1.03) | .088 |
Ischemic | 109 (1.12) | 148 (1.43) |
|
0.91 (0.70-1.18) | .479 |
Hemorrhagic | 29 (0.30) | 56 (0.55) |
|
0.60 (0.37-0.99) | .045 |
SE | <11† | 17 (0.17) |
|
0.61 (0.27-1.41) | .249 |
MB | 398 (4.06) | 779 (7.27) |
|
0.62 (0.54-0.70) | <.001 |
GI bleeding | 210 (2.16) | 384 (3.66) |
|
0.65 (0.54-0.77) | <.001 |
ICH | 68 (0.70) | 163 (1.57) |
|
0.52 (0.38-0.70) | <.001 |
Bleeding at other sites | 164 (1.68) | 320 (3.06) |
|
0.60 (0.49-0.74) | <.001 |